Abstract
Macrophages are critical components of the innate immune system that adapt their function based on local microenvironmental cues. In adipose tissue, macrophage polarization is intimately linked to metabolic regulation and inflammation. In this pilot study, we performed lipidomic profiling to characterize the phospholipid composition of pro-inflammatory (PI-ATM) and non-inflammatory (NI-ATM) macrophages isolated from visceral adipose tissue of living kidney donors. Tissue samples were processed, and macrophages were isolated and sorted using CD14 and CD16 markers. Lipids were extracted by methyl tert-butyl ether, and differences in the lipidome were analyzed using the optimized UHPLC-MS method. PI-ATM exhibited a higher abundance of lipids across various lipid classes than NI-ATM. Phosphatidylethanolamines and ether lipids derived from phosphatidylethanolamines and phosphatidylcholines were most frequently found among the significantly altered lipids. The majority of significantly altered lipid species contained an octadecenoic aliphatic chain. These findings suggest that alterations in membrane lipid composition - particularly ether lipids and phosphatidylethanolamines - may play a pivotal role in macrophage polarization and adipose tissue inflammation. Our study provides novel insights into the lipidomic regulation of macrophage function in human adipose tissue and identifies potential targets for therapeutic intervention in metabolic disorders.
Introduction
Macrophages are highly versatile cells of the innate immune system that can adapt their functionality based on their microenvironment, enabling them to perform specialized roles even under normal physiological conditions. These immunocytes eliminate infectious organisms and play a crucial role in maintaining tissue and organismal homeostasis1. Dynamic changes in the microenvironment can drive specific alterations in macrophage behavior, allowing them to adjust immune cell functioning appropriately.
In vitro studies have explored both pro-inflammatory and non-inflammatory macrophage phenotypes (PI-ATM and NI-ATM), identifying the stimulatory factors and characterizing the associated phenotypic and functional changes for each. However, a major limitation of this approach is its inability to imitate the complex microenvironment that macrophages encounter in specific tissues. For example, macrophages in adipose tissue are exposed to unique conditions, including high levels of fatty acids, insulin, metabolites, and adipose-derived hormones, which significantly influence their behavior. Overfeeding induces metabolic dysregulation, leading to the activation and polarization of inflammatory macrophages in adipose tissue. A strong connection between metabolic dysregulation in adipose tissue and the liver has been observed2. Resident macrophages in these tissues buffer fluctuation in intercellular lipids and maintain tissue homeostasis3,4. We were able to document that polarization changes occur even in the adipose tissue of healthy individuals, and these changes are related to factors of cardiovascular disease (body mass index (BMI), age, menopause, and non-HDL cholesterol)5,6,7. The specific phenotypes of metabolically activated PI-ATM, which, in addition to CD16, also strongly express CD36, characterize adipose tissue dysfunction. Our published data further demonstrated a direct positive link between PI-ATM and adipose tissue membrane lipids, namely palmitate and palmitoleate. In contrast, an opposite link was shown for omega-3 fatty acids8.
Over the years, numerous interactions between lipids and inflammation have been identified and extensively studied. Lipids influence membrane fluidity, which is closely connected with essential macrophage functions9,10. This link between inflammation and lipid metabolism was also shown in intracellular cell membranes, namely endoplasmic reticulum membranes11, mitochondrial, lysosomal, and endosomal macrophage membranes. These data suggest that changes in the lipidome act as modulators of inflammation. Our earlier work8 also demonstrated a pro-inflammatory effect of saturated fatty acids and, conversely, an anti-inflammatory effect of monounsaturated and polyunsaturated fatty acids. The pilot data we present here clearly identify the effect of lipid species on the polarization of pro-inflammatory macrophages. However, mutual effects cannot be excluded, as in vitro experiments revealed differences in the utilization of exogenous fatty acids between PI-ATM and NI-ATM12. Also, another study demonstrated that pro-inflammatory stimuli per se can alter macrophage lipidome13 or suppress lipid metabolic pathways. In conclusion, cellular lipid metabolism has emerged as an integral part of maintaining macrophage regulation and function as an integral part of the immune system homeostasis. Specifically, exposure of macrophages to phosphatidylcholine (PC) or phosphatidylserine (PS) triggers macrophage activity14.
Analyzing our data regarding the link between polar lipids and macrophage polarization in the context of the above-mentioned data leads us to focus on a more detailed lipidomic analysis of ATM’s phospholipid structure.
Methods
Characterization of individuals enrolled, sample preparation, and cell sorting
Living kidney donors were enrolled in the study performed at the Institute for Clinical and Experimental Medicine in Prague, Czech Republic. All were fully informed about the process of kidney donation and transplantation, as well as adipose tissue sampling during organ cleaning before transplantation. All individuals signed informed consent forms. The study’s design complied with the ethical principles of the Declaration of Helsinki and was approved by the Ethics Committee of the Institute for Clinical and Experimental Medicine and Thomayer Hospital, Prague, Czech Republic (No. 31113/23).
Lipoprotein concentrations and BMI of living kidney donors (LKD) were compared to the representative population sample. Thirty age and sex-matched individuals were selected from the participants of the WHO PostMONICA study, in which cardiovascular risk factors of 1% sample of 25-65-year-old individuals in 9 regions of the Czech Republic were analyzed (n = 2750).
For the final experiment, perirenal visceral adipose tissues were obtained from 10 living kidney donors (enrolled between March 2023 and March 2024) and processed immediately during hand-assisted nephrectomy. The samples were cleaned of all visible blood vessels and fibrous tissue and then finely minced by scissors. Following the wash-out residual blood, the adipose tissue was enzymatically digested in a collagenase solution (2 mg/ml; Collagenase from Clostridium histolyticum, CAS No. 9001-12-1, Sigma Type II, Sigma-Aldrich) prepared in 2% bovine serum albumin (BSA) in Dulbecco’s Phosphate-Buffered Saline (DPBS) without calcium and magnesium. Digestion was conducted in a shaking water bath at 37 °C. The resulting cell suspension was promptly cooled on ice, filtered through a 150 μm and 50 μm strainer, washed with DPBS containing BSA, and centrifuged. The cell suspension was subsequently labeled with fluorescently conjugated antibodies, including CD14-FITC (FITC Mouse Anti-Human CD14, BD Biosciences) and CD16-PE (Anti-Hu CD16 PE, EXBIO). Labeling was performed for 30 min at room temperature in the dark. Following antibody incubation, the cells were washed, and the pellet was resuspended in Hanks’ Balanced Salt Solution. 7-Aminoactinomycin D (7-AAD, BD Biosciences) was added to the cell suspension to assess cell viability. The prepared sample was then subjected to cell sorting using the BD FACSMelody system to isolate viable CD14⁺CD16⁺ and CD14⁺CD16⁻ cell populations. Gating strategy is shown in Sup. I. Figure 1. In this study, macrophages were isolated from visceral adipose tissue and sorted based on CD14 and CD16 expression, with CD14⁺CD16⁺ cells representing a pro-inflammatory subset (PI-ATM) and CD14⁺CD16⁻ cells representing a non-inflammatory phenotype (NI-ATM). On average we yielded 40,917 PI-ATM cells (min. 14859- max. 93671 cells/sample) and 42,169 NI-ATM cells (min. 11706- max. 78108 cells/sample) per sample. Isolated and sorted cells were stored in -80 °C until UHPLC-MS analysis. This simplified phenotyping is consistent with our previous studies on human ATMs5,15, and was used to enable sufficient cell yield for untargeted lipidomic analysis from small human tissue samples, balancing precise phenotypization with feasibility.
UHPLC-MS analysis
Solvents and additives of LC-MS purity were used for sample preparation and UHPLC-MS analysis: acetonitrile (VWR, PA, USA), water (Fisher Chemical, MA, USA), 2-propanol (Merck, NJ, USA), formic acid (Thermo Scientific, MA, USA), ammonium formate (Honeywell, NC, USA), and methanol (VWR, PA, USA). Lipids were extracted from macrophages using the methyl tert-butyl ether (MTBE, for HPLC, Honeywell, NC, USA) extraction16 with some modifications. Due to limited donor material and uncertain cell yields, we used the maximum number of cells available for each sample. Briefly, samples were placed in 2 mL Eppendorf tubes with 150 µL of cold methanol. 10 µL of EquiSPLASH (Avanti Polar Lipids, AL, USA) was added, and samples were sonicated for 10 min. Then 500 µL of cold MTBE was added, and the mixture was mixed at room temperature (1 h). In the next step, 125 µL of water was added, the mixture was mixed (5 min), and centrifuged (10 min, 500 g). The volume of 400 µL of the upper phase was transferred to a separate vial. The lower phase was re-extracted with 200 µL of the solvent mixture MTBE/methanol/water (10:3:2.5, v/v/v). The extraction was repeated, and 200 µL of the upper phase was combined with the first upper phase. The phases were evaporated and reconstituted in 200 µL of methanol/2-propanol (1:1, v/v). Untargeted lipidomics profiling was performed by coupling a Vanquish UHPLC chromatography system with TriPlus RTC autosampler to an Orbitrap IQ-X Tribrid mass spectrometer (ThermoFisher Scientific, MA, USA) with heated electrospray ionization. Mobile phase A was acetonitrile/water (60:40 (v: v)), and mobile phase B was 2-propanol/acetonitrile (90:10 (v: v)). Both mobile phase solutions contained 10 mM ammonium formate and 0.1% formic acid. The separations were performed on the Waters Acquity UPLC BEH C18 (2.1 × 100 mm, 1.7 μm) column operated at 55 °C and at a flow rate of 300 µL/min, with the elution gradient program as follows: 0–2.0 min, 0–43% B; 2.0–2.1 min, 43–55% B; 2.1–12.0 min, 55–65% B; 12.0–18.0 min, 65–85% B; 18.0–20.0 min, 85–100% B; 20.0–25.0 min, 100% B; 25.0–25.1 min, 100–0% B; and 25.1–30.0 min, 0% B. The injection volume was 5 µL for positive and 10 µL for negative ion modes. Full scan and MS2 HCD data acquisition were performed in a data-dependent setting for both ionization modes separately in the range of m/z 250–1600, 1 s cycle time, dynamic exclusion after 1 time for 3 s. The MS resolution 120 000 and the MS/MS resolution 15 000 were applied. The electrospray ionization voltage and the transfer capillary temperature were set to 3.5 kV and 350 °C, respectively. Quality control samples were prepared by pooling equal aliquots from all the samples in the study. These pooled QC samples were injected at the beginning, middle, and end of LC-MS sequence to monitor instrument stability and reproducibility. Lipid identification was performed using MS-DIAL 517. The following parameters were set in MS-DIAL: MS1 0.01 Da, MS2 0.025 Da, minimum peak height 10,000 amplitude. QC samples were used as the reference files for sample alignment. Features with 3-fold change sample max/blank average were filtered. Only the referenced matched annotations with match score > 1.3 were kept. Lipid annotations in MS-dial were manually cross-checked to ensure consistency between retention behavior and the degree of unsaturation to remove false positive identifications. Only the lipid annotation specifying the number of carbon atoms in each individual aliphatic chain and the number of double bonds were accepted, except for sphingomyelins (SM). Furthermore, annotated lipids exhibiting high abundance in blank samples were excluded from further consideration. To maximize detection sensitivity and minimize background lipid contamination, we performed extensive optimization of the HPLC-MS method, including solvent system testing based on the approach published by Čajka et al.18. Normalization to cell count was performed during data processing.
Statistical analysis
The power of the test for altered lipid levels in the CD16⁺ subset relative to the CD16⁻ subset was estimated using a paired two-sample means test, with means calculated from log-transformed lipid concentrations. The null hypothesis assumed a difference in lipid concentrations ≤ 0.176 (corresponding to a concentration ratio of 1.5). The alternative hypothesis was accepted when the observed difference including lower limit of 95% confidence interval surpassed this threshold. A sample size was considered sufficient if the statistical power exceeded 80% (0.8). Other statistical analysis was done with MetaboAnalyst software 6.0 (http://www.metaboanalyst.ca/). Before statistical analysis, the data were subjected to auto scaling. Volcano plot analysis was used to identify altered lipids (fold change > 2 and p-value < 0.05 by Student’s paired t-test). During processing, all “n.d.” values are replaced with one-fifth of the minimum positive value of the feature.
Results
Data of age, BMI, and lipoprotein parameters of the analyzed group of LKD did not differ in main clinical characteristics from the representative population sample of selected individuals (sex and age-matched), Table 1. This documents that the group of LKD was very similar to the general population. Only two of the LKD have a BMI of more than 30 kg/m2 (with a variation within group 22.31–30.78). The mean BMI in this group (27.65 ± 2.8 kg/m2) agrees with the recent shift in body composition and increase of visceral adipose tissue in most of the world’s populations19.
Based on untargeted lipidomic profiling of macrophages isolated from human adipose tissue, a total of 96 annotated lipid species were used for subsequent statistical analysis and comparative evaluation. In addition, over 90 triacylglycerol (TAG) species were annotated. However, they were excluded from statistical evaluation due to the inherently high abundance of TAGs in adipocytes and the possibility of nonspecific adsorption to macrophage surfaces, which could bias the interpretation.
Due to the limited amount of biological material, we were able to isolate only tens of thousands of macrophages per sample, representing approximately a tenfold reduction compared to the typically recommended minimum of 500,000 cells for robust lipidomic analysis20. This limitation significantly constrained the lipid detection and contributed to the relatively low number of reliably annotated lipid species. Nevertheless, significant differences in the lipidome were observed between NI-ATM and PI-ATM.
Among the annotated compounds, several ether lipids were identified and most likely correspond to plasmalogens21. However, the low abundance of these minor species limited spectral quality. At such low concentrations, diagnostic ions required for unambiguous identification of (1Z)-alkenyl ether linkages were not observed in HCD MS/MS spectra. Although statistically significant differences were observed for ether lipids, their low absolute concentrations and the untargeted nature of the lipidomic analysis precluded definitive discrimination between plasmalogens and other ether lipid forms.
The analysis indicates that PI-ATM contained a higher abundance of lipids across multiple lipid classes than NI-ATM (Sup. II Table 1). The lipidomic profiles were analyzed using partial least squares discriminant analysis (PLS-DA), a supervised multivariate method that identifies linear combinations of variables to optimally separate predefined groups. PLS-DA analysis revealed a clear separation between PI-ATM and NI-ATM macrophages (Fig. 1: A; cross-validation is shown in Sup. I. Figure 2). Notably, NI-ATM exhibited tighter clustering, indicating greater homogeneity among their lipid profiles compared to the more dispersed clustering observed for PI-ATM. A variable importance in projection (VIP) score plot, a key output of PLS-DA, ranked lipid features based on their contribution to group separation (Fig. 1: B). Higher VIP scores indicated lipids that play a significant role in distinguishing between groups. The analysis revealed that ether lipids (PE O- and PC O-) constitute 4% of the 15 most important lipids, indicating their significant role in differentiating the studied groups. Furthermore, most of the significant lipid features contained an 18:1 aliphatic chain, suggesting a potential structural or functional relevance of this fatty acid moiety in the observed lipidomic variations. A paired t-test offered an additional perspective on the results. As a parametric test, it compares the means of two related (paired) samples to determine whether there is a significant difference in lipid levels between them. The results are presented as a heatmap (Sup. I. Figure 3) highlighting 15 lipid species with a p-value < 0.05. The color coding reflects the relative abundance of lipid species in PI-ATM and NI-ATM macrophages. The paired t-test results aligned with the PLS-DA analysis, highlighting again plasmalogens as prominent among the significant lipid features, along with many lipids containing an 18:1 chain. Notably, 0% of the annotated lipid features identified in the paired t-test also overlap with those ranked by PLS-DA VIP scores, reinforcing the robustness of the findings.
PLS-DA of lipid profiling of pro-inflammatory and non-inflammatory adipose tissue macrophages. (A) Least squares discriminant analysis (PLS-DA) score plot based on lipid profiling of pro-inflammatory and non-inflammatory adipose tissue macrophages (PI-ATM and NI-ATM, respectively). (B) variable importance in projection (VIP) score plot showing the top 15 (score > 1.4) most important lipid features identified by PLS-DA. Colored boxes (on right) indicate relative concentration of corresponding metabolite.
Another statistical approach, the Volcano plot with FDR correction, was employed to identify significantly altered lipid features. In this plot, the x-axis represents the log2-transformed fold change (FC) of lipid species between paired conditions, while the y-axis displays the statistical significance as − log10(p-value). Lipid features with large fold changes and high statistical significance appear in the top left (downregulated) and top right (upregulated) regions of the plot. A Volcano plot analysis, using a significance threshold of p < 0.05 (Student’s paired t-test) and an FC > 2, identified 19 upregulated lipids in PI-ATM compared to NI-ATM (Fig. 2, Sup I. Table 1). To evaluate whether the sample size used in the pilot study was sufficient, a post hoc statistical power analysis was performed. The analysis was based on the concentration of significantly altered lipid species identified via volcano plot analysis. Using these values, the statistical power of the test was estimated for each of the 19 analytes (Sup I. Table 1). For 4 out of the 19 analytes, the estimated power exceeded the conventional threshold of 80%. Based on these calculations, the sample size employed in the pilot study can be considered adequate for drawing preliminary conclusions. According volcano plot analysis, phospholipids, including phosphatidylcholines (PC, ether-linked PC O-), phosphatidylethanolamines (PE, ether-linked PE O-), phosphatidylserine (PS), sphingomyelins (SM), and phosphatidylinositol (PI), showed the most pronounced relative increases. These lipids were predominantly enriched in saturated stearic acid (18:0) and monounsaturated oleic acid (18:1). Consistent with previous statistical analyses, ether-linked PC and PE exhibited the highest fold changes and were among the most strongly upregulated lipids (right side of Fig. 2). PC, PS, PE, and PI species containing fatty acid (FA) 18:1 or a combination of FA 18:1 and 18:0 exhibited the highest − log10 (p-value), as shown in Fig. 2 (top center).
Volcano plot of intact lipids. Volcano plot of lipids indicating lipid species that are significantly increased in the pro-inflammatory adipose tissue macrophages (PI-ATM) compared with non-inflammatory adipose tissue macrophages (NI-ATM) (fold change (FC) > 2 and p-value < 0.05 by Student’s paired t-test).
In the final statistical analysis, we examined the macrophage lipidome at the level of ester- and ether-linked aliphatic chains. To achieve this, total concentrations of individual aliphatic chains were extracted from the lipidomic data and compared using the Volcano plot with FDR correction. The plot (Fig. 3) revealed a highly significant increase in the content of monounsaturated fatty acid FA 18:1. Furthermore, a significant increase was also observed for ether-linked aliphatic chains (O-16:0, O-18:1, and O-16:2) in PI-ATM.
Volcano plot of ester-linked and ether-linked aliphatic chains. Volcano plot of ester-linked and ether-linked aliphatic chains indicating aliphatic moieties that are significantly increased in the pro-inflammatory adipose tissue macrophages (PI-ATM) compared with non-inflammatory macrophages (NI-ATM) (fold change (FC) > 2 and p-value < 0.05 by Student’s paired t-test).
In summary, statistical analyses revealed significant alterations in lipid profiles between PI-ATM and NI-ATM. Phospholipids, particularly plasmalogens, were crucial in distinguishing between these groups. In PI-ATM, multiple phospholipid classes were upregulated compared to NI-ATM, including PC, PC O-, PE, PE O-, PS, SM, and PI. At the fatty acyl chain level, in PI-ATM, a highly significant increase was observed in monounsaturated FA 18:1 and ether-linked aliphatic chains, including O-16:0, O-18:1, and O-16:2.
Discussion
Our findings reveal distinct untargeted lipidomic profiles between CD14⁺CD16⁺ and CD14⁺CD16⁻ macrophages in human visceral adipose tissue. The enrichment of phosphatidylethanolamines and ether-linked phospholipids in CD14⁺CD16⁺ macrophages is associated with their pro-inflammatory characteristics. While it remains unclear whether lipid composition drives macrophage polarization or results from it, the association suggests a functional link between membrane lipids and inflammatory status. These insights highlight the relevance of lipidomic profiling in understanding adipose tissue inflammation and its potential in identifying therapeutic targets.
In this study, we simplified the identification of adipose tissue macrophage (ATM) subpopulations using CD16 as the sole discriminatory marker. Due to limitations in sample volume and cell yield from living donor biopsies, we adopted this streamlined panel to ensure sufficient cell numbers for high-resolution lipidomic analysis. Notably, our previous work has shown that CD16⁺ ATMs express key pro-inflammatory genes at significantly higher levels than their CD16⁻ counterparts15. Furthermore, we previously identified an adipose tissue-specific pro-inflammatory subpopulation—characterized by high CD36 expression—that is exclusively present within the CD16⁺ subset, where it comprises 65–70% of all macrophages22. In contrast, nearly all CD16⁻ macrophages express the marker CD163 and display only low levels of CD36. This strategy does not encompass the full phenotypic diversity of ATMs, such as markers like CD206, CD163, and HLA-DR. We consider the use of CD14 and CD16 both appropriate and sufficient, given the study’s aims and the practical constraints of limited sample volume and cell yield. However, based on these findings, along with recent data challenging the specificity of CD163 as a definitive anti-inflammatory marker and the lack of significant differences in anti-inflammatory gene expression between CD16⁺ and CD16⁻ macrophages, we chose to use the broader term ‘non-inflammatory.’ This designation encompasses not only anti-inflammatory macrophages but also a broader spectrum of cells that lack definitive pro-inflammatory markers.
The age, BMI, and lipoprotein parameters of the LKD group did not differ from the representative population sample selected from the 1% population 25–64 years sample of the WHO PostMONICA survey in years 2016–201723. Therefore, we suppose that the studied subjects are representative of the Czech population in parameters of lipid metabolism. The mean BMI of 27.77 ± 2.77 kg/m2 documents that the Czech population is also shifting to more frequent overweight and obesity19. Interestingly, two LKD individuals with a BMI over 30 decreased the difference between the lipidomes of the two macrophage subpopulations (Red – PI-ATM, Green – NI-ATM in the heat map, Sup. I, Fig. 2).
Using the PLS-DA method to compare 96 lipid molecules with the lipid profiles of differently polarized macrophages in adipose tissue, we documented a clear separation between the two polarized groups (Fig. 1A). Figure 1B shows the lipids that contribute the most to the differentiation of these groups. The 95% confidence intervals slightly overlap. The confidence interval covers a larger area because there is a greater variation between points in the PI-ATM group. Nevertheless, only one NI-ATM point falls within the confidence interval of PI-ATM. The broader lipid profile observed in PI-ATM may result from our simplified classification of macrophages into two subpopulations. We demonstrated, that these subpopulations exhibit a more heterogenous nature compared to CD16 negative NI-ATM22.
Ether phospholipids, most commonly found as plasmalogens, have been largely neglected despite being isolated nearly a century ago and representing about 20% of total cellular phospholipids24. Ether lipids are present in various organs and lipoproteins25, and their importance is underscored by the steadily increasing number of publications on the topic26. They play a substantial role in maintaining membrane fluidity and are critical for molecular signaling27,28.
We were able to document the most significant differences in the plasmalogen content between PI-ATM and NI-ATM. Ether-bound fatty acids in the phosphatidyl ethanolamine and phosphatidyl choline are significantly increased in PI-ATM compared to NI-ATM (Fig. 2). We suppose that these lipids play an important role in the different polarization of macrophages in the adipose tissue of the LKD. It agrees with the published data21,29. In the both studies authors demonstrated that a decrease in cell fluidity is connected with a decrease in plasmalogens, and following plasmalogens supplementation, it can restore cell membrane fluidity. The PI-ATM function change might represent metabolic changes connected with the pathophysiology of adipose tissue30 moving from the lean adipose tissue to the increased volume of visceral tissue.
These data are in agreement with the importance of plasmalogens in pro-inflammatory macrophages playing a substantial role in cancer pathology31,32, obesity33, Alzheimer’s disease34, and even longevity35. In situ, polarization of adipose tissue macrophages is probably another pathology in which plasmalogens play a substantial role. It is important to stress that the increase of plasmalogens in PI-ATM in our study was documented in the group of LDK without substantial obesity presence.
Over the past decade, numerous studies have highlighted the critical role of membrane lipids in regulating macrophage function. Lipidomic has reached a groundbreaking advancement, enabling detailed analysis and interpretation of the effects of specific lipid species on human health. A recent lipidomic study36 analyzing over 800 lipid species shed light on their roles in transitioning from health to diseases, including those with known immunological backgrounds.
The importance of phosphatidylethanolamine in biological membranes has been recognized for several decades37, although its regulatory mechanisms remain unclear. Nevertheless, phosphatidylethanolamine contributes to plasma membrane structure38, microsomal membrane composition37, inflammation modulation39, and hepatic steatosis in experimental models40. The differences in phosphatidylethanolamine are the most important differences distinguishing PI-ATM and NI-ATM (Figs. 1B and 2).
One possible explanation of the phosphatidylethanolamine effect has been described in detail in an experimental model of steatohepatitis41. The authors demonstrated that replacing fatty acid in position 2 with oleic acid regulates the accumulation of triacylglycerols within hepatocytes (via intracellular receptors) and promotes liver steatosis. We would like to hypothesize that this mechanism might explain lipidomic differences between PI-ATM and NI-ATM, such as phosphatidylethanolamine, with a significant difference in oleic acid content (Figs. 2 and 3).
The wide range of anti-inflammatory effects of oleic acid on immune cells has been recently reviewed42. Studies have demonstrated that oleic acid influences pro-inflammatory genes and cytokine production in macrophages43. Oleate was shown to protect adipose tissue macrophages from apoptosis induced by saturated fatty acids, primarily through the downregulation of CD3644, a receptor that plays a central role in ATM pro-inflammatory polarization. Saturated fatty acids released from adipocytes induce pro-inflammatory changes in macrophages via TLR-4, triggering TNFα production. TNFα, in turn, activates lipolysis in adipocytes, further releasing saturated fatty acids and fueling a self-sustaining paracrine loop45.
Since this study is observational, it does not establish causality. Nonetheless, our findings are consistent with in vitro studies that have actively modulated macrophage polarization and plasma membrane composition. These studies involved either transformed macrophage-like cells46 or monocytes isolated in vivo - from animal models47 or human blood donors21 - that were subsequently polarized under controlled conditions. Notably, the only published study to directly influence myeloid cells in vivo, conducted in genetically modified zebrafish, demonstrated that plasmalogen metabolism is crucial for immune cell activation and modulation48. Although our observations are hypothesis-generating, they complement existing data and offer deeper insights into the role of plasmalogens in the immune system. An unusual preferential ether binding of palmitate and palmitoleate8 to the surface phospholipids of pro-inflammatory macrophages might direct further research of the macrophage role in the pro-inflammatory status of the adipose tissue and possible general pro-inflammatory shift.
Conclusion
In conclusion, our data adds significant new knowledge concerning how phospholipid composition relates to macrophage polarization in the adipose tissue. The lipid profile clearly separates PI-ATM and NI-ATM (Fig. 1). Data presented here indicate that ether lipids play a more significant role in adipose tissue homeostasis and inflammation. In addition, phosphatidylethanolamine might play a significant role in the difference between the two types of macrophages in adipose tissue. Although the mechanism of the regulative role of phosphatidylethanolamine as well as plasmalogens is still veiled, our data might stimulate following research in the field of macrophage polarization in adipose tissue.
Data availability
The mass spectrometry data have been deposited in the public repository Zenodo under [https://doi.org/10.5281/zenodo.15296922](https:/doi.org/10.5281/zenodo.15296922).
Abbreviations
- 7-AAD:
-
7-Aminoactinomycin D
- ATM:
-
Adipose tissue macrophages
- NI-ATM:
-
Non-inflammatory adipose tissue macrophages
- BSA:
-
Bovine serum albumin
- PC O-:
-
Ether-linked phosphatidylcholine
- FA:
-
Fatty acid
- HCD:
-
Higher-energy collisional dissociation
- PLS-DA:
-
Least squares discriminant analysis
- LKD:
-
Living kidney donors
- BMI:
-
Body mass index
- MTBE:
-
Methyl tert-butyl ether
- PC:
-
Phosphatidylcholine
- PE:
-
Phosphatidylethanolamines
- PE O-:
-
Phosphatidylethanolamines ether-linked
- PI:
-
Phosphatidylinositol
- PS:
-
Phosphatidylserine
- PI-ATM:
-
Pro-inflammatory adipose tissue macrophages
- VIP:
-
Variable importance in projection
References
Lazarov, T., Juarez-Carreño, S., Cox, N. & Geissmann, F. Physiology and diseases of tissue-resident macrophages. Nature 618(7966), 698–707 (2023).
Azzu, V., Vacca, M., Virtue, S., Allison, M. & Vidal-Puig, A. Adipose tissue-liver cross talk in the control of whole-body metabolism: Implications in nonalcoholic fatty liver disease. Gastroenterology 158(7), 1899–1912 (2020).
Kosteli, A. et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Investig. 120(10), 3466–3479 (2010).
Jaitin, D. A. et al. Lipid-Associated macrophages control metabolic homeostasis in a Trem2-Dependent manner. Cell 178(3), 686–98e14 (2019).
Poledne, R., Kralova Lesna, I., Kralova, A., Fronek, J. & Cejkova, S. The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue. J. Lipid Res. 57(10), 1899–1905 (2016).
Kralova Lesna, I. et al. Cardiovascular disease predictors and adipose tissue macrophage polarization: is there a link? Eur. J. Prev. Cardiol. 25(3), 328–334 (2018).
Lesna, K. I. et al. Macrophage subsets in the adipose tissue could be modified by sex and the reproductive age of women. Atherosclerosis 241, 255–258 (2015).
Poledne, R. et al. Polarization of macrophages in human adipose tissue is related to the fatty acid spectrum in membrane phospholipids. Nutrients 12(1), 8 (2019).
Bohdanowicz, M. & Grinstein, S. Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis. Physiol. Rev. 93(1), 69–106 (2013).
Fessler, M. B. & Parks, J. S. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J. Immunol. 187(4), 1529–1535 (2011).
Yeudall, S. et al. Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism. Sci. Adv. 8(47), eabq1984 (2022).
Morgan, P. K. et al. Macrophage polarization state affects lipid composition and the channeling of exogenous fatty acids into endogenous lipid pools. J. Biol. Chem. 297(6), 101341 (2021).
Fang, H. et al. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173(1), 360–366 (2004).
Cauvi, D. M., Hawisher, D., Derunes, J., Rodriguez, E. & De Maio, A. Membrane phospholipids activate the inflammatory response in macrophages by various mechanisms. Faseb j. 38(8), e23619 (2024).
Bartuskova, H. et al. Links between macrophages in perivascular adipose tissue and arterial wall: a role in atherosclerosis initiation? Int. Angiol. 41(5), 433–443 (2022).
Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49(5), 1137–1146 (2008).
Tsugawa, H. et al. MS-DIAL: data-independent MS/MS Deconvolution for comprehensive metabolome analysis. Nat. Methods. 12(6), 523–526 (2015).
Cajka, T. et al. Exploring the impact of organic solvent quality and unusual adduct formation during LC-MS-Based lipidomic profiling. Metabolites 13(9), 966 (2023).
Heymsfield, S. B. & Wadden, T. A. Mechanisms, Pathophysiology, and management of obesity. N. Engl. J. Med. 376(3), 254–266 (2017).
Rakusanova, S. & Cajka, T. Tips and tricks for LC-MS-based metabolomics and lipidomics analysis. Trac-Trend Anal. Chem. 180, 117940 (2024).
Wallner, S. et al. Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages. PLoS One. 13(10), e0205706 (2018).
Kralova Lesna, I. et al. Characterisation and comparison of adipose tissue macrophages from human subcutaneous, visceral and perivascular adipose tissue. J. Translational Med. 14(1), 208 (2016).
Cífková, R. et al. 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985–2016/17. PLoS One. 15(5), e0232845 (2020).
Nagan, N. & Zoeller, R. A. Plasmalogens: biosynthesis and functions. Prog Lipid Res. 40(3), 199–229 (2001).
Bozelli, J. C. Jr., Azher, S. & Epand, R. M. Plasmalogens and chronic inflammatory diseases. Front. Physiol. 12, 730829 (2021).
Jiménez-Rojo, N. & Riezman, H. On the road to unraveling the molecular functions of ether lipids. FEBS Lett. 593(17), 2378–2389 (2019).
Glaser, P. E. & Gross, R. W. Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion. Biochemistry 33(19), 5805–5812 (1994).
Banerjee, S. et al. The Vps13-like protein BLTP2 is pro-survival and regulates phosphatidylethanolamine levels in the plasma membrane to maintain its fluidity and function. BioRxiv(2024).
Wallner, S. et al. Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation. PLoS One. 9(4), e94102 (2014).
Hill, D. A. et al. Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. Proc. Natl. Acad. Sci. U S A. 115(22), E5096–e105 (2018).
Papin, M. et al. Endogenous ether lipids differentially promote tumor aggressiveness by regulating the SK3 channel. J. Lipid Res. 65(5), 100544 (2024).
Benjamin, D. I. et al. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc. Natl. Acad. Sci. U S A. 110(37), 14912–14917 (2013).
Schooneveldt, Y. L., Paul, S., Calkin, A. C. & Meikle, P. J. Ether lipids in obesity: from cells to population studies. Front. Physiol. 13, 841278 (2022).
Jové, M. et al. Ether lipid-mediated antioxidant defense in alzheimer’s disease. Antioxid. (Basel). 12(2), 293 (2023).
Cedillo, L. et al. Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in Caenorhabditis elegans. Elife 12, e82210 (2023).
Hornburg, D. et al. Dynamic lipidome alterations associated with human health, disease and ageing. Nat. Metab. 5(9), 1578–1594 (2023).
Valtersson, C., Filipsson, L. & Dallner, G. Localization of phosphatidylethanolamine in microsomal membranes and regulation of its distribution by the fatty acid composition. J. Lipid Res. 27(7), 731–741 (1986).
Prades, J., Funari, S. S., Escribá, P. V. & Barceló, F. Effects of unsaturated fatty acids and triacylglycerols on phosphatidylethanolamine membrane structure. J. Lipid Res. 44(9), 1720–1727 (2003).
Santos, M. et al. The non-enzymatic oxidation of phosphatidylethanolamine and phosphatidylserine and their intriguing roles in inflammation dynamics and diseases. FEBS Lett. 598(17), 2174–2189 (2024).
Li, Z. et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell. Metab. 3(5), 321–331 (2006).
Petkevicius, K. et al. TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis. Nat. Commun. 13(1), 6020 (2022).
Santa-María, C. et al. Update on anti-inflammatory molecular mechanisms induced by oleic acid. Nutrients 15(1), 224 (2023).
Santamarina, A. B. et al. Anti-inflammatory effects of oleic acid and the anthocyanin Keracyanin alone and in combination: effects on monocyte and macrophage responses and the NF-κB pathway. Food Funct. 12(17), 7909–7922 (2021).
Kim, D. H., Cho, Y. M., Lee, K. H., Jeong, S. W. & Kwon, O. J. Oleate protects macrophages from palmitate-induced apoptosis through the downregulation of CD36 expression. Biochem. Biophys. Res. Commun. 488(3), 477–482 (2017).
Suganami, T., Nishida, J. & Ogawa, Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25(10), 2062–2068 (2005).
Rubio, J. M., Astudillo, A. M., Casas, J., Balboa, M. A. & Balsinde, J. Regulation of phagocytosis in macrophages by membrane ethanolamine plasmalogens. Front. Immunol. 9, 1723 (2018).
Gil-de-Gómez, L., Astudillo, A. M., Lebrero, P., Balboa, M. A. & Balsinde, J. Essential role for ethanolamine plasmalogen hydrolysis in bacterial lipopolysaccharide priming of macrophages for enhanced arachidonic acid release. Front. Immunol. 8, 1251 (2017).
Arroyo, A. B. et al. Peds1 deficiency in zebrafish results in myeloid cell apoptosis and exacerbated inflammation. Cell. Death Discov. 10(1), 388 (2024).
Acknowledgements
We thank Magdalena Spitalnikova Vertatova for assistance with cell sorting.Funding- The research was supported by the project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID Project No. LX22NPO5104) - Funded by the European Union - Next Generation EU.
Funding
The research was supported by the project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID Project No. LX22NPO5104) - Funded by the European Union - Next Generation EU.
Author information
Authors and Affiliations
Contributions
R. P., V. V. and J. C. conceptualization; Š. S., V. V., I. K. L. and K. Pr. methodology; K. Pr., K. Pa., B. M., S. K., and Š. S. investigation; M. P. statistical analysis; K. Pr. and Š. S. visualization; J.F. – sampling in the operational theatre; J.C. and I.K.L. funding acquisition; D. S. supervision; Š. S., R. P. and I. K. L. writing–original draft; V. V., Š. S., R. P., I. K. L. and J. C. writing–review & editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval and consent to participate
The study’s design was approved by the Ethics Committee of the Institute for Clinical and Experimental Medicine and Thomayer Hospital, Prague, Czech Republic (No. 31113/23).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Vrkoslav, V., Pražáková, K., Strnad, Š. et al. Lipidomics of polarized macrophages in the human adipose tissue. Sci Rep 16, 3018 (2026). https://doi.org/10.1038/s41598-025-32912-z
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-32912-z


